Patents by Inventor J. Collins

J. Collins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11965452
    Abstract: A method for detecting a contaminant in a vehicle coolant system during service includes contacting a chromophore impregnated strip and a heat transfer fluid sample, where the chromophore impregnated strip includes a complexing agent selected to form a complex with the contaminant that causes a color change in the chromophore impregnated strip and thereby indicates the presence of the contaminant in the heat transfer fluid sample.
    Type: Grant
    Filed: January 25, 2023
    Date of Patent: April 23, 2024
    Assignee: GM GLOBAL TECHNOLOGY OPERATIONS LLC
    Inventors: Thomas J. Chapaton, Nicholas Paul William Pieczonka, William Reginald Collin, Ratandeep Singh Kukreja
  • Publication number: 20240123132
    Abstract: A drain cassette for a dialysis unit has a fluid channel between venous and arterial connection ports, and a valve may controllably open and close fluid communication between a drain outlet port and the venous connection port or the arterial connection port. A blood circuit assembly and drain cassette may be removable from the dialysis unit, e.g., by hand and without the use of tools. A blood circuit assembly may include a single, unitary member that defines portions of a pair of blood pumps, control valves, channels to accurately position flexible tubing for an occluder, an air trap support, and/or other portions of the assembly. A blood circuit assembly engagement device may assist with retaining a blood circuit assembly on the dialysis unit, and/or with removal of the assembly. An actuator may operate a retainer element and an ejector element that interact with the assembly.
    Type: Application
    Filed: December 22, 2023
    Publication date: April 18, 2024
    Applicant: DEKA Products Limited Partnership
    Inventors: Kevin L. Grant, Michael J. Wilt, Brian D. Tracey, Brett A. Rudolf, David E. Collins, Lisa A. Gustin, James D. Dale, Jesse T. Bodwell
  • Patent number: 11957570
    Abstract: An ophthalmic device includes an optic including an optic axis and a closed-loop haptic structure coupled to the optic via a frame surrounding the optic, the closed-loop haptic structure including a closed loop extending from first and second attachment points to the frame. The closed loop includes a first hinge and a second hinge. The first hinge has a first section having a first component extending in a first angular direction, a second section having a second component extending in a second angular direction opposite to the first angular direction, and a first connecting section between the first section and the second section. The second hinge has a third section having a third component extending in the second angular direction, a fourth section having a fourth component extending in the first angular direction, the fourth section being connected to the second section to form the closed loop.
    Type: Grant
    Filed: June 18, 2021
    Date of Patent: April 16, 2024
    Assignee: Alcon Inc.
    Inventors: Sung Kyu Lee, Stephen John Collins, Ian Michael Marks, Jonathan David Mccann, Jian Liu, Douglas Brent Wensrich, Stephen J. Van Noy
  • Publication number: 20240117073
    Abstract: The present invention relates to specific binding members, particularly antibodies and fragments thereof, which bind to amplified epidermal growth factor receptor (EGFR) and to the de2-7 EGFR truncation of the EGFR. In particular, the epitope recognized by the specific binding members, particularly antibodies and fragments thereof, is enhanced or evident upon aberrant post-translational modification. These specific binding members are useful in the diagnosis and treatment of cancer. The binding members of the present invention may also be used in therapy in combination with chemotherapeutics or anti-cancer agents and/or with other antibodies or fragments thereof.
    Type: Application
    Filed: April 26, 2023
    Publication date: April 11, 2024
    Inventors: Lloyd J. Old, Terrance Grant Johns, Con Panousis, Andrew M. Scott, Christoph Renner, Gerd Ritter, Achim Jungbluth, Elisabeth Stockert, Vincent Peter Collins, Webster K. Cavenee, Huei-Jen Su Huang, Antony Wilks Burgess, Edouard C. Nice, Anne Murray, George Mark
  • Publication number: 20240084345
    Abstract: Methods for converting mixtures of anthocyanins occurring in fruit or vegetable juice or extract into particular anthocyanin molecules having desirable colorant properties are provided herein. The method of the present disclosure can be employed to increase the amount of particular anthocyanin molecules, while lowering the total number of anthocyanin molecules present in the natural juice and/or extract. The disclosure is also directed to anthocyanin molecules prepared by the methods of present disclosure and to enzymes capable of catalyzing reactions that provide such effects.
    Type: Application
    Filed: July 21, 2023
    Publication date: March 14, 2024
    Applicants: MARS, INCORPORATED, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Thomas M. Collins, Rebecca J. Robbins, Randall Powers, Justin Siegel, Pamela Ruth Denish, Kathryn Gwendolyn Guggenheim
  • Patent number: 11920307
    Abstract: Provided are tissue webs, and products produced therefrom, that are generally durable, flexible and have improved cross-machine direction (CD) properties, such as CD tensile energy absorption (CD TEA), CD stretch and CD modulus. The inventive tissue products generally comprise multiple tissue plies, such as two or more plies, that have been prepared by through-air drying and more preferably by through-air drying without creping. Moreover, the plies may be produced in a through-air drying process that utilizes a transfer fabric positioned between the forming fabric and the through-air drying fabric where the transfer fabric imparts the nascent web with a high degree of CD strain.
    Type: Grant
    Filed: July 20, 2022
    Date of Patent: March 5, 2024
    Inventors: Mark W. Sachs, Richard A. Zanon, Lynda E. Collins, Kevin J. Vogt, Christopher L. Satori
  • Publication number: 20240067957
    Abstract: Genetic circuits that control transgene expression in response to pre-defined transcriptional cues would enable the development of smart therapeutics. The present disclosure relates to engineered programmable single-transcript RNA sensors in which adenosine deaminases acting on RNA (ADARs) autocatalytically convert trigger hybridization into a translational output. This system amplifies the signal from editing by endogenous ADAR through a positive feedback loop. Amplification is mediated by the expression of a hyperactive, minimal ADAR variant and its recruitment to the edit site via an orthogonal RNA targeting mechanism. This topology confers high dynamic range, low background, minimal off-target effects, and a small genetic footprint. The circuits and systems disclosed herein leverage an ability to detect single nucleotide polymorphisms and modulate translation in response to endogenous transcript levels in mammalian cells.
    Type: Application
    Filed: June 22, 2023
    Publication date: February 29, 2024
    Applicants: Massachusetts Institute of Technology, President and Fellows of Harvard College
    Inventors: James J. Collins, Raphael Gayet, Katherine IIia, Shiva Razavi, Nathaniel Tippens, Kehan Zhang, Jack Chen, Jonathan Chen, Makoto Lalwani
  • Patent number: 11916613
    Abstract: The present technology provides solutions that enable accurate measuring of frequency response on a network (e.g., cable network, fiber optic network) through frequency sweep testing. In various embodiments, the present technology provides a remote transmitter test unit that can be physically deployed at various points in a network. The present technology provides for on demand sweep testing. A remote transmitter test unit or headend test unit can periodically transmit a query message and, based on a response to the query message, can initiate a sweep test. The present technology provides for automatic generation of a sweep profile for a sweep test. Based on an analysis of a frequency spectrum on a network, the sweep profile provides parameters for conducting a sweep test. The present technology provides for Orthogonal Frequency-Division Multiplexing (OFDM) table generation and OFDM sweep testing.
    Type: Grant
    Filed: January 31, 2022
    Date of Patent: February 27, 2024
    Assignee: VeEX Inc.
    Inventors: Christopher C. Collins, Charles J. Kiss, Jr., Michael Collins, Thomas R. Morley
  • Publication number: 20240055092
    Abstract: A system and method of using an intelligent telehealth platform to generate a recommended treatment plan based on daypart feedback to treat a malady of a user. The method includes obtaining a user profile dataset of a user. The user profile dataset includes a plurality of user goals for a plurality of dayparts of a day, each daypart of the plurality of dayparts is respectively associated with one or more user goals of the plurality of user goals. The method includes generating a plurality of treatment plans to treat a malady of the user based on the user dataset and a machine learning model trained to predict cannabis treatment responses, each treatment plan is for using one or more cannabis products during a respective daypart of the plurality of dayparts of the day. The method includes transmitting the plurality of treatment plans to a client device.
    Type: Application
    Filed: August 15, 2022
    Publication date: February 15, 2024
    Inventors: David C. Batista, Stacey Batista, Benjamin P. Caplan, Sean J. Collins, Birch Norton, Kristen P. Parton, Christine R. Pillsbury, Geordie McClelland
  • Publication number: 20240024383
    Abstract: Provided herein are compositions and methods comprising engineered microorganisms and their use for locally degrading an antibiotic in the gastrointestinal tract to prevent or limit death of beneficial flora.
    Type: Application
    Filed: December 1, 2021
    Publication date: January 25, 2024
    Applicants: PRESIDENT AND FELLOWS OF HARVARD COLLEGE, MASSACHUSETTS INSTITUTE OF TECHNOLOGY
    Inventors: Andres Fernando CUBILLOS, James J COLLINS
  • Publication number: 20240004221
    Abstract: The present disclosure relates to ophthalmic devices such as ophthalmic lenses. An ophthalmic device may comprise an ophthalmic lens for at least one of slowing, retarding or preventing myopia progression. The ophthalmic lens may comprise a center zone with a negative power for myopic vision correction; and at least one treatment zone surrounding the center zone, the at least one treatment zone having a power profile comprising an ADD power, the at least one treatment zone having a surface shape comprising a portion of a generally toroidal shape, wherein the at least one treatment zone is arranged as to form a continuous surface with the center zone.
    Type: Application
    Filed: September 15, 2023
    Publication date: January 4, 2024
    Inventors: Noel A. Brennan, Xu Cheng, Jaclyn V. Hernandez, Michael J. Collins, Brett A. Davis, Fan Yi, Derek Dean Nankivil
  • Publication number: 20230384114
    Abstract: A system includes a personal protective equipment (PPE) configured to be worn by an agent. The PPE includes a sensor assembly comprising a radar device configured to generate radar data, a microphone configured to capture speech input from the agent, and an inertial measurement device configured to generate inertial data. The system includes a computing device configured to: process sensor data from the sensor assembly, the sensor data including at least the radar data and the inertial data, to generate pose data of the agent based on the processed sensor data, the pose data including a location and an orientation of the agent as a function of time, to process the speech input to identify an item of interest in an environment in which the PPE is deployed, and to form mapping information for the environment with the item of interest being marked, based on the processed speech input.
    Type: Application
    Filed: September 1, 2021
    Publication date: November 30, 2023
    Inventors: John M. KRUSE, Elisa J. COLLINS, Nicholas T. GABRIEL, Richard J. SABACINSKI, Darin K, THOMPSON, Adam C. NYLAND, Samuel J. FAHEY
  • Patent number: 11788156
    Abstract: The invention provides novel and versatile classes of riboregulators, including inter alia activating and repressing riboregulators, switches, and trigger and sink RNA, and methods of their use for detecting RNAs in a sample such as a well and in modulating protein synthesis and expression.
    Type: Grant
    Filed: September 16, 2021
    Date of Patent: October 17, 2023
    Assignees: President and Fellows of Harvard College, Trustees of Boston University
    Inventors: Alexander A. Green, Peng Yin, James J. Collins, Jongmin Kim
  • Patent number: 11789292
    Abstract: The present disclosure relates to ophthalmic devices such as ophthalmic lenses. An ophthalmic device may comprise an ophthalmic lens for at least one of slowing, retarding or preventing myopia progression. The ophthalmic lens may comprise a center zone with a negative power for myopic vision correction; and at least one treatment zone surrounding the center zone, the at least one treatment zone having a power profile comprising an ADD power, the at least one treatment zone having a surface shape comprising a portion of a generally toroidal shape, wherein the at least one treatment zone is arranged as to form a continuous surface with the center zone.
    Type: Grant
    Filed: March 9, 2021
    Date of Patent: October 17, 2023
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Noel A. Brennan, Xu Cheng, Jaclyn V. Hernandez, Michael J. Collins, Brett A. Davis, Fan Yi, Derek Dean Nankivil
  • Patent number: 11781149
    Abstract: Embodiments disclosed herein provide artificial expression systems comprising multivalent transcription factor complexes for cooperative transcription factor assembly and modulating gene expression. More specifically, engineered synthetic transcription factors are recruited and structurally organized on synthetic gene circuits using molecular clamps, where the strength of intra-complex interactions can be modulated for fine tuning of gene expression as desired.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: October 10, 2023
    Assignee: Trustees of Boston University
    Inventors: Ahmad S. Khalil, Caleb J. Bashor, Nikit Patel, James J. Collins
  • Publication number: 20230313215
    Abstract: Embodiments disclosed herein provide artificial expression systems comprising multivalent transcription factor complexes for cooperative transcription factor assembly and modulating gene expression. More specifically, engineered synthetic transcription factors are recruited and structurally organized on synthetic gene circuits using molecular clamps, where the strength of intra-complex interactions can be modulated for fine tuning of gene expression as desired.
    Type: Application
    Filed: May 31, 2023
    Publication date: October 5, 2023
    Applicant: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: Ahmad S. Khalil, Caleb J. Bashor, Nikit Patel, James J. Collins
  • Patent number: 11768386
    Abstract: The present disclosure relates to ophthalmic devices such as ophthalmic lenses. An ophthalmic device may comprise an ophthalmic lens for at least one of slowing, retarding or preventing myopia progression. The ophthalmic lens may comprise a center zone with a negative power for myopic vision correction; and at least one treatment zone surrounding the center zone, the at least one treatment zone having a power profile comprising an ADD power, the at least one treatment zone having a surface shape comprising a portion of a generally toroidal shape, wherein the at least one treatment zone is arranged as to form a continuous surface with the center zone.
    Type: Grant
    Filed: December 23, 2019
    Date of Patent: September 26, 2023
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Noel A. Brennan, Xu Cheng, Jaclyn V. Hernandez, Michael J. Collins, Brett A. Davis, Fan Yi, Derek Dean Nankivil
  • Patent number: 11754859
    Abstract: The present disclosure relates to ophthalmic devices such as ophthalmic lenses. An ophthalmic device may comprise an ophthalmic lens for at least one of slowing, retarding or preventing myopia progression. The ophthalmic lens may comprise a center zone with a negative power for myopic vision correction; and at least one treatment zone surrounding the center zone, the at least one treatment zone having a power profile comprising an ADD power, the at least one treatment zone having a surface shape comprising a portion of a generally toroidal shape, wherein the at least one treatment zone is arranged as to form a continuous surface with the center zone.
    Type: Grant
    Filed: July 28, 2022
    Date of Patent: September 12, 2023
    Assignee: Johnson & Johnson Vision Care, Inc
    Inventors: Noel A. Brennan, Xu Cheng, Jaclyn V. Hernandez, Michael J. Collins, Brett A. Davis, Fan Yi, Derek Dean Nankivil
  • Publication number: 20230277489
    Abstract: Provided herein are compositions and methods to improve treatment of chronic infections, and reduce, delay, or inhibit formation of biofilms, using specific combinations of aminoglycoside antibiotics and treatment with one or more proton motive force (PMF) stimulating compounds. These novel methods are easily adapted to clinical settings as toxicity and efficacy of the antibiotics and metabolites used have already been studied in vivo, and as dosing for both the antibiotics and metabolites are known.
    Type: Application
    Filed: May 25, 2022
    Publication date: September 7, 2023
    Applicants: TRUSTEES OF BOSTON UNIVERSITY, THE GENERAL HOSPITAL CORPORATION
    Inventors: James J. Collins, Sylvain Meylan, Samuel Moskowitz
  • Publication number: 20230242563
    Abstract: Various processes for preparing C4 aldoses and/or ketones thereof are described. Various processes are described for preparing C4 aldoses and/or ketones thereof from feed compositions comprising glycolaldehyde. Also, various processes for preparing useful downstream products and intermediates, such as erythritol and erythronic acid, from the C4 aldoses and/or ketones thereof are described.
    Type: Application
    Filed: April 30, 2021
    Publication date: August 3, 2023
    Inventors: William J. Collins, Josh Terrian, James Brazdil, Kevin Martin